Prescribing information

 

Useful tools and resources for HCPs to share with patients who have been prescribed ▼Beovu® (brolucizumab) for the treatment of wet AMD.

__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

 

“”

BEOVU AND YOU: PATIENT BOOKLET

This booklet contains information for patients about:

  • What is Beovu and why they have been prescribed it
  • What to expect from treatment with Beovu, including possible side effects
  • Their appointments and how to monitor their vision (including Amsler grid)
  • Where to find further information and support.

Download

 

 

AMD, age-related macular degeneration; HCP, healthcare professional.

BEO20-C039n September 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]